制酸薬のグローバル市場予測(~2027年)

◆英語タイトル:Antacids Market Research Report by Formulation, Drug Class, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが発行した調査報告書(360iR22DC258)◆商品コード:360iR22DC258
◆発行会社(リサーチ会社):360iResearch
◆発行日:2022年10月
◆ページ数:227
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD4,949 ⇒換算¥732,452見積依頼/購入/質問フォーム
Enterprise LicenseUSD9,949 ⇒換算¥1,472,452見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

360iResearch社の本調査レポートでは、2021年に7,161.04百万ドルであった世界の制酸薬市場規模が、2022年に7,508.50百万ドルになり、2027年まで年平均5.02%で成長して9,612.48百万ドルに達すると予測しています。本レポートでは、制酸薬の世界市場を広く調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、剤型別(液体、粉末、錠剤)分析、薬品クラス別(酸中和剤、H2拮抗薬、運動促進剤、プロトンポンプ阻害剤)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などを以下の構成でまとめています。本書では、AstraZeneca PLC、Baxter Laboratories Pty Ltd.、Bayer AG、Bodywise International LLC、C.H. Boehringer Sohn AG & Ko. KG、Cadila Pharmaceuticals Limited、GlaxoSmithKline PLC、GM Pharmaceuticals, Inc.、Johnson & Johnsonなどの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト

・世界の制酸薬市場規模:剤型別
- 液体型制酸薬の市場規模
- 粉末型制酸薬の市場規模
- 錠剤型制酸薬の市場規模

・世界の制酸薬市場規模:薬品クラス別
- 酸中和剤の市場規模
- H2拮抗薬の市場規模
- 運動促進剤の市場規模
- ロトンポンプ阻害剤の市場規模

・世界の制酸薬市場規模:地域別
- 南北アメリカの制酸薬市場規模
アメリカの制酸薬市場規模
カナダの制酸薬市場規模
ブラジルの制酸薬市場規模

- アジア太平洋の制酸薬市場規模
日本の制酸薬市場規模
中国の制酸薬市場規模
インドの制酸薬市場規模
韓国の制酸薬市場規模
台湾の制酸薬市場規模

- ヨーロッパ/中東/アフリカの制酸薬市場規模
イギリスの制酸薬市場規模
ドイツの制酸薬市場規模
フランスの制酸薬市場規模
ロシアの制酸薬市場規模

- その他地域の制酸薬市場規模

・競争状況
・企業情報

The Global Antacids Market size was estimated at USD 7,161.04 million in 2021 and expected to reach USD 7,508.50 million in 2022, and is projected to grow at a CAGR 5.02% to reach USD 9,612.48 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Antacids to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Formulation, the market was studied across Liquid, Powder, and Tablet.

Based on Drug Class, the market was studied across Acid Neutralizers, H2 Antagonist, Promotility Agents, and Proton Pump Inhibitor.

Based on Distribution Channel, the market was studied across Hospital Pharmacy and Retail Pharmacy.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Antacids market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antacids Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antacids Market, including AstraZeneca PLC, Baxter Laboratories Pty Ltd., Bayer AG, Bodywise International LLC, C.H. Boehringer Sohn AG & Ko. KG, Cadila Pharmaceuticals Limited, GlaxoSmithKline PLC, GM Pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., Procter and Gamble Company, Sanofi S.A., Torrent Pharmaceuticals Ltd., and WellSpring Pharmaceutical Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Antacids Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antacids Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antacids Market?
4. What is the competitive strategic window for opportunities in the Global Antacids Market?
5. What are the technology trends and regulatory frameworks in the Global Antacids Market?
6. What is the market share of the leading vendors in the Global Antacids Market?
7. What modes and strategic moves are considered suitable for entering the Global Antacids Market?

❖ レポートの目次 ❖

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing population suffering from gastroesophageal reflux disease, or GERD due to unhealthy lifestyle choices and consumption of drugs resulting in acidity
5.1.1.2. Availability of information creating awareness about GERD
5.1.1.3. Sedentary and stressed lifestyle necessitates demanding antacids
5.1.2. Restraints
5.1.2.1. Home remedies and other alternatives for acidity related issues
5.1.3. Opportunities
5.1.3.1. Development of more instantly effective and long lasting antacids
5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
5.1.4. Challenges
5.1.4.1. FDA drug recall due to significant health side effects associated with the antacids
5.2. Cumulative Impact of COVID-19

6. Antacids Market, by Formulation
6.1. Introduction
6.2. Liquid
6.3. Powder
6.4. Tablet

7. Antacids Market, by Drug Class
7.1. Introduction
7.2. Acid Neutralizers
7.3. H2 Antagonist
7.4. Promotility Agents
7.5. Proton Pump Inhibitor

8. Antacids Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy

9. Americas Antacids Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Antacids Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Antacids Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AstraZeneca PLC
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Baxter Laboratories Pty Ltd.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bayer AG
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bodywise International LLC
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. C.H. Boehringer Sohn AG & Ko. KG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cadila Pharmaceuticals Limited
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. GlaxoSmithKline PLC
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. GM Pharmaceuticals, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Johnson & Johnson
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Novartis AG
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Pfizer Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Procter and Gamble Company
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Sanofi S.A.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Torrent Pharmaceuticals Ltd.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. WellSpring Pharmaceutical Corporation
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 制酸薬のグローバル市場予測(~2027年)(Antacids Market Research Report by Formulation, Drug Class, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆